Coston McIsaac & Partners increased its stake in shares of Lam Research Co. (NASDAQ:LRCX – Free Report) by 904.2% in the 4th quarter, HoldingsChannel.com reports. The firm owned 1,677 shares of the semiconductor company’s stock after buying an additional 1,510 shares during the quarter. Coston McIsaac & Partners’ holdings in Lam Research were worth $121,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Atwood & Palmer Inc. acquired a new position in shares of Lam Research in the fourth quarter worth $27,000. West Oak Capital LLC grew its stake in Lam Research by 50.9% in the fourth quarter. West Oak Capital LLC now owns 400 shares of the semiconductor company’s stock valued at $29,000 after purchasing an additional 135 shares in the last quarter. Finley Financial LLC acquired a new position in Lam Research in the 4th quarter worth about $30,000. Householder Group Estate & Retirement Specialist LLC raised its stake in shares of Lam Research by 159.1% during the 4th quarter. Householder Group Estate & Retirement Specialist LLC now owns 500 shares of the semiconductor company’s stock worth $36,000 after purchasing an additional 307 shares in the last quarter. Finally, Laurel Wealth Advisors LLC acquired a new stake in shares of Lam Research during the 4th quarter valued at about $37,000. 84.61% of the stock is owned by hedge funds and other institutional investors.
Lam Research Stock Up 0.9 %
NASDAQ LRCX opened at $75.15 on Thursday. The stock’s 50 day simple moving average is $75.62 and its 200 day simple moving average is $79.15. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.53 and a quick ratio of 1.74. Lam Research Co. has a one year low of $68.87 and a one year high of $113.00. The firm has a market cap of $96.69 billion, a PE ratio of 24.29, a price-to-earnings-growth ratio of 1.53 and a beta of 1.45.
Lam Research Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Wednesday, January 8th. Stockholders of record on Wednesday, December 11th were paid a dividend of $0.23 per share. The ex-dividend date of this dividend was Wednesday, December 11th. This represents a $0.92 annualized dividend and a dividend yield of 1.22%. Lam Research’s dividend payout ratio (DPR) is currently 29.74%.
Analysts Set New Price Targets
LRCX has been the subject of several recent research reports. Cantor Fitzgerald raised shares of Lam Research from a “neutral” rating to an “overweight” rating and set a $100.00 target price for the company in a research report on Thursday. Mizuho decreased their price objective on shares of Lam Research from $95.00 to $90.00 and set an “outperform” rating for the company in a report on Friday, January 10th. Wells Fargo & Company raised their target price on Lam Research from $82.00 to $85.00 and gave the company an “equal weight” rating in a report on Thursday. Stifel Nicolaus reiterated a “buy” rating and set a $100.00 price target (down previously from $105.00) on shares of Lam Research in a research note on Thursday, October 24th. Finally, KeyCorp raised Lam Research from a “sector weight” rating to an “overweight” rating and set a $95.00 price objective on the stock in a research note on Friday, January 17th. Seven investment analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $95.72.
View Our Latest Analysis on Lam Research
Lam Research Company Profile
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.
Read More
- Five stocks we like better than Lam Research
- What Are Dividend Challengers?
- ASML: Strengths and Upside Remain Despite DeepSeek Worries
- Stock Analyst Ratings and Canadian Analyst Ratings
- Royal Caribbean Soars, But Smooth Sailing Isn’t Guaranteed
- The Risks of Owning Bonds
- Kimberly-Clark: A Regal Opportunity in This Dividend King
Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Co. (NASDAQ:LRCX – Free Report).
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.